Skip to main content
. 2021 Oct 12;11:725336. doi: 10.3389/fonc.2021.725336

Table 1.

Clinical sample information.

Sample number Patient's identification number Age Subtype Tumor burden (%) in BM Red blood cell (RBC,10^12/L) White blood cell (WBC,10^9/L) Platelet (10^9/L)
AML Patients 1 # 695438 29 M5 29.8 66 25.9 55
2# 665972 19 M2 36.3 63 49.9 23
3# 687524 34 M1 75.7 39 36.6 75
4# 742586 49 M5 54.6 38 46.4 45
5# 675823 58 M5 79.2 48 62.1 46
6# 668545 44 M1 68.2 56 66.6 45
7# 698657 35 M1 58.3 44 35.5 68
8# 699982 61 M5 59.1 55 73.2 38
9# 659325 52 M4 27.5 67 21.1 48
10# 695837 61 M4 52.8 50 45.5 61
Sample Number Gender Age
Healthy Volunteers 1# Male 36
2# Female 42
3# Female 21
4# Male 28
5# Male 31

Clinical sample information of 10 acute myeloid leukemia (AML) patients and five healthy volunteers for Figure 1C .